Thursday, October 18, 2018 9:16:31 AM
#1. NO WALGREENS OR OMHE WRITTEN PURCHASE AGREEMENT DOCUMENT HAS BEEN PROVIDED TO PROVE "WALGREENS PURCHASED MALECON" "CLAIM"!
#2. NO WALGREENS OR OMHE WRITTEN SEC FILING COMPANY TRANSACTION DOCUMENT HAS BEEN PROVIDED TO PROVE "WALGREENS PURCHASED MALEON" "CLAIM"!
#3. NO WALGREENS OR OMHE WRITTEN PRESS RELEASE DOCUMENT HAS BEEN PROVIDED TO PROVE "WALGREENS PURCHASED MALEON" "CLAIM"!
#4. NO WALGREENS OR OMHE WRITTEN FEDERAL TRADE COMMISSION APPROVAL DOCUMENT HAS BEEN PROVIDED TO PROVE "WALGREENS PURCHASED MALEON" "CLAIM"! (WALGREENS WENT THROUGH A LENGTHY PROCESS TO REQUEST APPROVAL FROM THE FEDERAL TRADE COMMISSION TO PURCHASE RITE-AID PHARMACIES.)
#5. NO PHOTOGRAPHS OF WALGREENS OCCUPYING MALECON'S STRIP MALL LOCATION HAS BEEN PROVIDED TO PROVE "WALGREENS PURCHASED MALEON" "CLAIM"!
#6. "IF IT'S NOT WRITTEN, IT DOESN'T EXIST"! IF THERE "WALGREENS REALLY PURCHASED MALECON PHARMACY", THERE WOULD DEFINITELY BE SOME KIND OF "WRITTEN DOCUMENT" "OFFICIALLY" "DOCUMENTING" THE COMPANY-TO-COMPANY TRANSACTION!
#7. I HAVE BEEN REQUESTING A "WALGREEN PURCHASED MALECON" "DOCUMENT" DAILY FOR OVER ~3 WEEKS AND STILL HAVE NOT BEEN PROVIDED A DOCUMENT OR EVEN A LINK TO A DOCUMENT!
#8. UNTIL EITHER A WALGREENS OR OMHE "WRITTEN DOCUMENT" IS PROVIDED THAT PROVES "WALGREENS PURCHASED MALECON PHARMACY", THE "WALGREENS PURCHASED MALECON" "CLAIM" IS PURE "BS"!
#9. "PHONE CALLS" ARE BY NO MEANS ANY WAY OF "OFFICIALLY" VALIDATING ANY VERBAL "CLAIM" ABOUT ANY COMPANY!!! DO YOU THINK THE SEC WOULD ACCEPT ANY "VERBAL" SEC FILINGS FOR COMPANY TRANSACTIONS?... HELL NO!!!
MUCH MORE THAN ENOUGH SAID!!!
GLAD I OWN OMHE SHARES!!!
– LINKED PHOTOS & VIDEOS SHOW "FACTUAL" INFORMATION & PROVIDE EVIDENCE TO "CLAIMS".
– "A PICTURE IS WORTH 1000 WORDS"!!!—an old saying
– PHOTOS/VIDEOS DON'T LIE.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM